Здоровье
Bristol-Myers Squibb приобретет Mirati за $5,8 млрд.
Bristol-Myers Squibb announced it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can
GSK подписывает соглашение о вакцине против опоясывающего лишая с Zhifei
Zhifei, China’s largest vaccine company, will pay UK drugmaker GSK $3.05 billion for exclusive distribution rights to GSK’s shingles vaccine in the world’s second-largest pharmaceutical
Гейтс пожертвовал $40 миллионов на расширение доступа к мРНК-вакцинам в Африке
The Bill & Melinda Gates Foundation will donate $40 million to a Belgian biotech company and two leading African vaccine manufacturers in a bid to
В этом десятилетии денге «взлетит» на юге Европы, в США и Африке.
Dengue will become a major threat in the southern United States, southern Europe and new parts of Africa this decade, according to the WHO’s chief
Птичий грипп заразил стадо коммерческой птицы в США
The US has detected its first case of bird flu on a commercial poultry farm since April, in a flock of 47,300 turkeys in Jerauld
FDA США все еще не удовлетворено отзывом Philips
The US Food and Drug Administration said it is still not satisfied with the way Dutch health technology firm Philips has handled a major product
США планируют вывести препарат Merck от COVID на коммерческий рынок
The US government will stop distributing free doses of Merck & Co’s COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it
Мексика сообщила о птичьем гриппе H5N1 у диких уток
Mexican animal safety authorities confirmed the first case of H5N1 bird flu in wild birds on Wednesday after declaring the country’s poultry farms free of
Британия предлагает запретить курение сигарет подрастающему поколению
The British government on Wednesday proposed banning the younger generation from ever buying cigarettes. The move would create some of the world’s toughest smoking regulations
Данные Amgen о лекарстве от рака легких на поздней стадии «неадекватны»
US Food and Drug Administration experts said Amgen’s late-stage trial may not be sufficient to confirm the effectiveness of its lung cancer drug, as the